Sweet: the quest for a sugar alternative

Sweetened trials highlight the complexities of replacing sugar in food and its influence on taste, texture, and health outcomes.
Sweeteners, once niche, are now ubiquitous and central to debates on obesity, diabetes, and nutrition.
Sweeteners range from “artificial” compounds like aspartame to natural options like stevia and monk fruit; each has trade-offs.
The World Health Organization recently advised against sweeteners for weight control or disease prevention due to mixed evidence, contrasting with randomized trials that show promising outcomes.
Mechanistic, observational, and randomized controlled trials provide differing insights into sweeteners’ effects on the body, revealing gaps in fully understanding their impact on health.
Randomized controlled trials suggest that replacing sugar with sweeteners lowers blood sugar and insulin spikes without increasing appetite or energy intake, and may aid in weight management.
Concerns about sweeteners, like aspartame being “possibly carcinogenic,” lack strong human evidence at current consumption levels.
Future research focuses on long-term effects, especially on specific populations like children and diabetics, and the development of better sweetener blends via advanced technologies like artificial intelligence.